Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in InventoryChange in InventoryChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InflaRx (IFRX) Capital Expenditures (2022 - 2026)

InflaRx's Capital Expenditures history spans 5 years, with the latest figure at -$11083.4 for Q1 2026.

  • On a quarterly basis, Capital Expenditures fell 0.87% to -$11083.4 in Q1 2026 year-over-year; TTM through Mar 2026 was $135796.7, a 141.98% increase, with the full-year FY2025 number at $134672.9, up 168.88% from a year prior.
  • Capital Expenditures hit -$11083.4 in Q1 2026 for InflaRx, down from $266960.6 in the prior quarter.
  • Over the last five years, Capital Expenditures for IFRX hit a ceiling of $266960.6 in Q4 2025 and a floor of -$147408.4 in Q4 2022.
  • Historically, Capital Expenditures has averaged $5573.7 across 5 years, with a median of -$10988.0 in 2025.
  • The widest YoY moves for Capital Expenditures: up 225.02% in 2025, down 5467.55% in 2025.
  • Tracing IFRX's Capital Expenditures over 5 years: stood at -$147408.4 in 2022, then surged by 192.73% to $136689.6 in 2023, then plummeted by 39.91% to $82135.4 in 2024, then skyrocketed by 225.02% to $266960.6 in 2025, then crashed by 104.15% to -$11083.4 in 2026.
  • Business Quant data shows Capital Expenditures for IFRX at -$11083.4 in Q1 2026, $266960.6 in Q4 2025, and -$102844.1 in Q3 2025.